TNF is already targeted by biologic therapeutic approaches [78], and IFN regulatory factors 3 and 7 (IRF3 and IRF7) have been implicated in the IFN signature in lupus previously [54, 79, 80]. The gene discussed is IRF3; the disease is systemic lupus erythematosus.